In this report we detail the evolution of our previously reported thiophene isoxazole BET inhibitor chemotype exemplified by CPI-3 to a novel bromodomain selective chemotype (the methyl isoxazoleazepine chemotype) exemplified by carboxamide 23. The methyl isoxazoleazepine chemotype provides potent inhibition of the bromodomains of the BET family, excellent in vivo PK across species, low unbound clearance, and target engagement in a MYC PK-PD model.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2015.03.045 | DOI Listing |
Publication Analysis
Top Keywords
chemotype exemplified
8
methyl isoxazoleazepine
8
isoxazoleazepine chemotype
8
development methyl
4
methyl isoxazoleazepines
4
isoxazoleazepines inhibitors
4
inhibitors bet
4
bet report
4
report detail
4
detail evolution
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!